Literature DB >> 7527437

Effect of antiandrogen treatment on chemical hepatocarcinogenesis in rats.

B Matsuura1, Y Taniguchi, Y Ohta.   

Abstract

We studied the effect of antiandrogen treatment on the Solt-Farber model of hepatocarcinogenesis in male Sprague-Dawley rats. The size and number of the liver tumors were reduced by various antiandrogen treatments (orchiectomy, an LH-RH analog, and chlormadinone acetate). In addition, the proportion of poorly differentiated carcinomas was decreased by the antiandrogen treatment, while that of well-differentiated trabecular or glandular carcinomas was increased. The bromodeoxyuridine labeling index of the tumor cells was significantly decreased after the antiandrogen treatment. The expression of rat androgen receptor mRNA in carcinoma tissue was increased when compared to control liver tissue, and was decreased after the antiandrogen treatment. Orchiectomy had the greatest inhibitory effect on carcinoma, although the effect of chemical orchiectomy using an LH-RH analog was almost similar to that of orchiectomy. These results suggest that the clinical application of antiandrogen therapy for human hepatocellular carcinoma might be possible in the future.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527437     DOI: 10.1016/s0168-8278(05)80393-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis.

Authors:  Wen-Lung Ma; Cheng-Lung Hsu; Chun-Chieh Yeh; Ming-Heng Wu; Chiung-Kuei Huang; Long-Bin Jeng; Yao-Ching Hung; Tze-Yi Lin; Shuyuan Yeh; Chawnshang Chang
Journal:  Hepatology       Date:  2012-06-05       Impact factor: 17.425

2.  Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level.

Authors:  Chi-Ming Chiu; Shiou-Hwei Yeh; Pei-Jer Chen; Ti-Jung Kuo; Ching-Ju Chang; Po-Jen Chen; Wan-Jen Yang; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-26       Impact factor: 11.205

3.  The influence of high serum testosterone levels on the long-term prognosis in male patients undergoing hepatectomy for early stage hepatocellular carcinoma without vascular invasion.

Authors:  Min-Che Lin; Cheng-Chung Wu; Shao-Bin Cheng; Tse-Jia Liu; Fang-Ku P'eng
Journal:  World J Surg       Date:  2007-07       Impact factor: 3.352

4.  Cellular distribution of androgen receptors in the liver.

Authors:  S A Hinchliffe; S Woods; S Gray; A D Burt
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

Review 5.  Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.

Authors:  Mamta Kalra; Jary Mayes; Senait Assefa; Anil-K Kaul; Rashmi Kaul
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

6.  The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals.

Authors:  Junjie Xu; Hui Lin; Gonghui Li; Yin Sun; Jiang Chen; Liang Shi; Xiujun Cai; Chawnshang Chang
Journal:  EBioMedicine       Date:  2016-07-14       Impact factor: 8.143

7.  Increasing AR by HIF-2α inhibitor (PT-2385) overcomes the side-effects of sorafenib by suppressing hepatocellular carcinoma invasion via alteration of pSTAT3, pAKT and pERK signals.

Authors:  Junjie Xu; Longbo Zheng; Jiang Chen; Yin Sun; Hui Lin; Ren-An Jin; Minyue Tang; Xiao Liang; Xiujun Cai
Journal:  Cell Death Dis       Date:  2017-10-12       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.